Pregled bibliografske jedinice broj: 675808
Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activity
Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activity // Gut, 59 (2010), 12; 1728-1729 doi:10.1136/gut.2009.194100 (međunarodna recenzija, pismo, znanstveni)
CROSBI ID: 675808 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Serum S100A12 as a new marker for inflammatory bowel disease and its relationship with disease activity
Autori
Brinar, Marko ; Cleynen, I. ; Coopmans, T. ; Van Assche, G. ; Rutgeerts, P. ; Vermeire, S.
Izvornik
Gut (0017-5749) 59
(2010), 12;
1728-1729
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo, znanstveni
Ključne riječi
Inflammatory bowel; serum marker; S100A12
Sažetak
We read with interest the work by Foell et al in which the authors report increased serum levels of the protein S100A12, a marker of neutrophil activation, in patients with Crohn's disease and ulcerative colitis in comparison with healthy controls.1 They also demonstrated a correlation between S100A12 in the serum and disease activity as well as a prompt decrease of S100A12 levels in response to infliximab therapy. More recently, the same group showed that faecal S100A12 had even superior sensitivity and specificity than faecal calprotectin in distinguishing active inflammatory bowel disease (IBD) from healthy controls.2 All together, these findings make S100A12 a promising biomarker in IBD.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
108-1081874-1917 - Upalne bolesti crijeva (Crohnova bolest i ulcerozni kolitis) (Vucelić, Boris, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Marko Brinar
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
